Tokai Pharma (TKAI) Will Discontinue Enrollment in ARMOR2 Expansion Trial

August 22, 2016 4:03 PM

Tokai Pharma (NASDAQ: TKAI) disclosed the following on Monday:Item 7.01. Regulation FD DisclosureTokai Pharmaceuticals, Inc. (“Tokai”) has determined to discontinue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found